In concert, these data suggest that DRD2 activation is involved in the control of glucose metabolism and that reduced dopaminergic transmission via DRD2 contributes to the metabolic phenotype (insulin resistance) of obese animals. The gene discussed is DRD2; the disease is Insulin resistance.